RAYMOND JAMES & ASSOCIATES - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,029,494
+2.9%
162,125
-1.8%
0.00%0.0%
Q1 2024$1,000,433
+2.0%
165,088
+2.1%
0.00%0.0%
Q4 2023$981,137
+28.2%
161,637
-10.9%
0.00%0.0%
Q3 2023$765,453
+53.0%
181,387
+12.4%
0.00%
Q2 2023$500,300
+123.0%
161,3870.0%0.00%
Q1 2023$224,328
-30.2%
161,3870.0%0.00%
Q4 2022$321,160
-1.5%
161,3870.0%0.00%
Q3 2022$326,000
-38.3%
161,387
-2.8%
0.00%
-100.0%
Q2 2022$528,000
-24.6%
165,973
-1.2%
0.00%0.0%
Q1 2022$700,000
-15.3%
167,973
-2.6%
0.00%0.0%
Q4 2021$826,000
-11.7%
172,473
-1.5%
0.00%0.0%
Q3 2021$935,000
+5.5%
175,052
+1.2%
0.00%0.0%
Q2 2021$886,000
-22.6%
173,052
+1.8%
0.00%0.0%
Q1 2021$1,144,000
+43.9%
170,052
-2.3%
0.00%0.0%
Q4 2020$795,000
+17.6%
174,019
-0.1%
0.00%0.0%
Q3 2020$676,000
-15.4%
174,229
+3.9%
0.00%0.0%
Q2 2020$799,000
+37.0%
167,764
+0.1%
0.00%0.0%
Q1 2020$583,000
-7.3%
167,514
+28.3%
0.00%0.0%
Q4 2019$629,000
+122.3%
130,514
+33.7%
0.00%
Q3 2019$283,000
-9.6%
97,634
+123.5%
0.00%
Q2 2019$313,000
-41.7%
43,693
+15.3%
0.00%
-100.0%
Q1 2019$537,000
-15.4%
37,894
-19.3%
0.00%0.0%
Q4 2018$635,000
-51.3%
46,935
-20.2%
0.00%
-50.0%
Q3 2018$1,305,000
+81.0%
58,795
+33.7%
0.00%
+100.0%
Q2 2018$721,00043,9610.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders